Healthcare companies develop
and market new ways of treating
and preventing disease
Caring for patients is their
job. Their support in applying,
developing and evaluating
treatments is key
Safety and efficacy are
monitored closely by the
processes and institutions
that approve treatments
Public healthcare systems
and private insurance reimburse
treatments to patients
Authorities provide healthcare
legislation and budget for their
Scientists and healthcare
specialists lead the way or
the healthcare of the future
voices the needs of
requires large investments.
Shareholders’ return on
investment must be
sufficient for sustaining
Director of CABIMER, Former Minister of Health, SpainHealth is not the result of a single action.
Caregiver and father of Steve, a schizophrenia patientThe future has to be about partnership working.
Dr. James Kingsland
President, National Association of Primary Care, UK and local commissionerWe also need to be transparent in common goals.
Early stage dementia patient & dementia advocateInclude dementia patients in your programmes and ask their opinions.
Chief Executive, Myeloma UKIt’s incumbent on industry and academics to work together.
Director General, European Organisation of Research and Treatment of CancerThe current healthcare challenges are forcing everyone to work together.
Director, National Centre for Pharmacoeconomics, IrelandIt’s about communication, openness and transparency.
Former Government Minister, Ireland
Director of several companiesThe first moves must come from the pharmaceutical companies.
Founder & President, Epac Onlus
Patients Organisation (Hepatitis C)The pharma industry has to be more transparent.
Head of communications
National French Association of PsoriasisDo not forget the patient – this is the goal.
Kyle Jacques Rose
Founder & Managing Director,
Delta PM Diabetes Patient AdvocacyInclude patient representatives from across the chronic diseases.
Reader in Health Policy
London School of Economics Health
United KingdomUnderstanding the needs of healthcare systems requires some upscaling of skills in the pharma industry.
Dr. Rafael Bengoa
Health Department Director
DEUSTO Business School, SpainEmerging new healthcare models are providing the industry and healthcare professionals a common agenda to work in partnership.
Janssen Europe, the Middle-East and Africa (EMEA) in a nutshell
- Pharmaceutical company of Johnson & Johnson
- More than 14,000 employees
- Local offices in more than 30 countries
- 8 R&D Centres in EMEA
- 8 Manufacturing sites
- Activities in more than 100 countries